The analgesic effects of 30 mg of intramuscular ketorolac were compared with those of rectal indomethacin in 100 mg and 200 mg doses in 66 patients in a single-blinded trial. Pain scores and the incidence of nausea and vomiting were assessed at 30, 60 and 120 minutes postoperatively, at discharge (4 hours) and on the evening of surgery. Area under the curve of pain scores versus time for pain at 30, 60 and 120 minutes postoperatively was significantly lower in the ketorolac group compared to indomethacin 100 mg and 200 mg groups. There were no significant differences in the pain scores at discharge or at home on the evening of surgery. At 60 minutes postoperatively there was significantly more nausea and vomiting in the indomethacin 200 mg group; at all other timepoints there was no significant difference between the groups with regard to nausea and vomiting. The power of the study to determine the significance of side-effects between the groups was low.
Non-steroidal anti-inflammatory drugs (NSAIDs) are being increasingly used as sole postoperative analgesic agents following minor surgery or as an adjunct to opiates following more major surgery. Ketorolac is a recently released NSAID that is marketed in a parenteral and oral formulation.
Although demonstrated to be a useful adjunct to opiates for postoperative pain relief and as a sole analgesic agent following minor surgery, to date there have been few studies showing a clear benefit of ketorolac over other NSAIDs in these roles. Most of the studies performed have shown no discernible difference between ketorolac and a number of other NSAIDs with regard to analgesia or side-effect profile [1] [2] [3] [4] [5] [6] [7] [8] .
As a supplementary or sole postoperative analgesic, intramuscular ketorolac has the advantage of parenteral administration in the postoperative fasting patient. However, indomethacin suppositories have also been shown to be very effective in this clinical setting but at a greatly reduced cost. To date there has only been one comparison of indomethacin and ketorolac in which no difference was demonstrated between the two with regard to analgesia efficacy 4 . Further, this study used a dose of 100 mg indomethacin whereas a number of recent studies have used a loading dose of 200 mg of indomethacin [9] [10] .
METHODS
Sixty-six ASA group 1 or 2 patients were enrolled in the trial. Institutional ethics committee approval was obtained and all patients gave written informed consent.
All patients were premedicated with omnopon and scopolamine (0.2 and 0.004 mg/kg respectively) IM one hour preoperatively. Anaesthesia was induced with propofol and the patients were intubated after muscle relaxation was achieved with vecuronium. Anaesthesia was maintained with nitrous oxide, oxygen and enflurane.
After induction, by the sequential selection of prepared and randomized envelopes, each patient was randomized into one of three groups: 30 mg intramuscular ketorolac, 100 mg rectal indomethacin or 200 mg rectal indomethacin. The appropriate NSAID was given after induction of anaesthesia and prior to the commencement of surgery. During the procedure all patients received prochlorperazine mesylate 0.17 mg/kg IV. Postoperatively all patients had access to paracetamol 1.0 g four-hourly p.r.n. as a supplementary analgesic.
Demographic data, number of wisdom teeth removed and extraction difficulty as assessed by the surgeon on a five-point scale were recorded for all patients. Postoperatively pain scores were assessed by a 100 mm visual analog scale at 30, 60 and 120 minutes and at discharge (approximately four hours postoperatively).
Pain scores on the evening of surgery were assessed via a phone interview the following day on a ten-point verbal scale, as was the amount of supplementary analgesia used that evening. The amount of supplementary analgesia required during the postoperative recovery phase and the presence or absence of nausea and vomiting while in hospital and at home was recorded.
One-way analysis of variance or t-tests were used for normally distributed variables. Ordinal data were analysed using Chi square test. A P value of <0.05 was considered significant.
RESULTS
Data from all 66 patients entered in the study were available for analysis, but only 53 of the 66 patients were able to be contacted the following day. Therefore their data with regard to pain scores, supplementary analgesia and incidence of nausea and vomiting on the evening of surgery were not available.
The demographic data are summarized in Table 1 . There was a significantly higher proportion of females in the indomethacin 200 mg group (P=0.03); there were no other significant differences in the variables.
Pain scores for the three groups at the various timepoints are shown in Figure 1 and Table 2 . The area under the curve (AUC) of pain score versus time for pain at 30, 60 and 120 minutes postoperatively shows a significantly lower value (P<0.01) for the ketorolac group, 734 (154) expressed as mean (SD) compared to the lower dose, 1765 (304) or higher dose, 2167 (309) indomethacin groups. There were no significant differences in the pain scores between any of the groups at discharge or at home on the evening of surgery. Table 3 shows incidence of nausea and vomiting within the groups. At 60 minutes postoperatively the incidence of nausea and vomiting was significantly there were no significant differences in nausea and vomiting between the groups. However, there was less than 15% power to detect a difference between groups at these timepoints.
There was no significant difference between any of the groups in the number of supplementary analgesia tablets taken postoperatively or at home (Table 4 ).
DISCUSSION
At all timepoints the patients in the ketorolac group had lower pain scores than the patients in either of the two indomethacin groups. The area under the curve of pain score versus time for the first three timepoints was used to summarize the serial observations and showed that results for the ketorolac group were significantly lower than that for the two indomethacin groups. As the time of discharge and evening interview was not able to be standardized they could not be included in the AUC analysis. However, comparison of the three groups at these two timepoints individually revealed no difference between the groups.
The initial analgesic advantage of intramuscular ketorolac over the rectal indomethacin possibly relates to its faster absorption; with time, the indomethacin is able to offer the same degree of analgesia. Interestingly we were not able to demonstrate any analgesic advantage of the indomethacin 200 mg over the indomethacin 100 mg at any timepoint.
Though these results are in conflict with a number of other comparisons of ketorolac with other NSAID drugs 1-8 , the differing NSAIDs and differing modes of administration used for the comparison and the differing settings in which the analgesia was tested makes direct comparison difficult. Morley-Forster et al 4 compared intramuscular ketorolac 30 mg with rectal indomethacin 100 mg in the setting of day case gynaecological or breast surgery and found no difference between the two groups. This protocol most closely resembles our own with regard to the treatment groups; however, all patients had access to fentanyl in the postoperative period. The use of this rescue analgesia will reduce the pain scores between the groups. At the same time, as the fentanyl was administered on a prn basis, there are problems in interpreting fentanyl requirements as a measure of the analgesia efficacy of the NSAID used in each group. Ideally a combination of VAS pain scores and PCA rescue medication will provide the best primary end-point for differentiating between alternative analgesic techniques. However, this was not a practical proposition in the surgical setting we encountered. As in our study, Forbes et al 3 used the setting of extraction of wisdom teeth to compare ketorolac with a number of other NSAID and combination analgesics. Though ketorolac 10 and 20 mg orally provided better analgesia than acetaminophen and acetaminophen-codeine combinations, there was no improvement over the analgesia provided by ibuprofen 400 mg. Once again, though the surgical setting is identical, the differing doses and modes of administration of the ketorolac make direct comparison difficult.
Honig et al 1 In our study the initial improved analgesia over the indomethacin groups was achieved without a demonstrable increase in the incidence of nausea and vomiting. The indomethacin 200 mg group had a higher incidence of nausea and vomiting at 60 minutes post surgery but this may reflect the higher incidence of females in this group. Only Rusy et al 8 found an increase in adverse side-effects in using ketorolac, and this was in the setting of post paediatric tonsillectomy pain in which the ketorolac caused more bleeding than acetaminophen while not providing any advantage in terms of analgesia.
In conclusion intramuscular ketorolac 30 mg given after induction of anaesthesia provides superior pain relief over both rectal indomethacin 100 mg and indomethacin 200 mg in the first 120 minutes postoperatively after removal of wisdom teeth. 
